MASI

Masimo Corporation [MASI] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

MASI Stock Summary

Top 10 Correlated Stocks

MASI


In the News

10:46 29 Mar 2024 MASI

Is Masimo (MASI) Stock Outpacing Its Medical Peers This Year?

Here is how Masimo (MASI) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.

08:16 29 Mar 2024 MASI

Masimo (MASI) Plans Consumer Business Spin-Off to Drive Growth

Masimo (MASI) is evaluating a proposed separation of its consumer audio and consumer health product business in a bid to improve the profitability of the healthcare business.

08:11 29 Mar 2024 MASI

Masimo (MASI) Soars 3.3%: Is Further Upside Left in the Stock?

Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

04:54 29 Mar 2024 MASI

Masimo CEO on potential split, proxy battle and spinning off consumer business

Joe Kiani, Masimo CEO, joins 'Closing Bell: Overtime' to discuss the company spinning off its consumer business.

10:01 29 Mar 2024 MASI

Activist investor plans second fight at Masimo, sending shares up 12%

Quentin Koffey's Politan Capital waged a successful proxy fight at Masimo last year, and it is now seeking two more board seats.

06:46 29 Mar 2024 MASI

Masimo's stock rallies on report of looming activist campaign, disclosure of spinoff plan

Masimo Corp.'s stock MASI, +1.40% was up 12% in premarket trading on Monday after The Wall Street Journal reported that activist investor Politan Capital Management plans to nominate two more members to the patient-monitoring technology company's board. Politan Capital, which was launched by Quentin Koffey, already has two seats on the company's board.

10:45 29 Mar 2024 MASI

Masimo Stock Surges After Proposed Spinoff of Consumer Business

Share in Masimo (MASI) surged 13% in extended trading on Friday after the company announced that it is planning a spinoff of its consumer unit to improve the profitability of its primary healthcare business.

08:18 29 Mar 2024 MASI

Activist investor Politan plans second proxy battle at Masimo, WSJ reports

Activist investor Politan Capital Management, which last year won two seats on the board of medical technology company Masimo Corp , is planning a second proxy battle for two more seats, the Wall Street Journal reported on Sunday.

05:56 29 Mar 2024 MASI

Masimo plans to spinoff consumer business

Medical technology company Masimo Corp said on Friday it is evaluating a proposed spinoff of its consumer business, which includes its consumer health and audio products, sending shares up 13% in extended trading.

09:01 29 Mar 2024 MASI

Here's Why You Should Add Masimo (MASI) to Your Portfolio Now

Masimo's (MASI) R&D activities raise optimism about the stock.

MASI Financial details

Company Rating
Strong Buy
Market Cap
7.14B
Income
81.5M
Revenue
2.05B
Book val./share
25.85
Cash/share
3.14
Dividend
-
Dividend %
-
Employees
3.8K
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
67.73
Forward P/E
50.93
PEG
-15.92
P/S
2.83
P/B
4.7
P/C
46.72
P/FCF
-102.71
Quick Ratio
0.83
Current Ratio
2.14
Debt / Equity
0.68
LT Debt / Equity
0.64
-
-
EPS (TTM)
1.54
EPS next Y
2.88
EPS next Q
0.83
EPS this Y
-42.54%
EPS next Y
86.69%
EPS next 5Y
125.19%
EPS last 5Y
-15.94%
Revenue last 5Y
16.91%
Revenue Q/Q
14.62%
EPS Q/Q
220%
-
-
-
-
SMA20
5.95%
SMA50
16.6%
SMA100
70.53%
Inst Own
67.43%
Inst Trans
0.78%
ROA
3%
ROE
7%
ROC
0.07%
Gross Margin
50%
Oper. Margin
8%
Profit Margin
4%
Payout
-
Shs Outstand
52.91M
Shs Float
48.81M
-
-
-
-
Target Price
152
52W Range
75.22-198.0
52W High
-25.91%
52W Low
+95.59%
RSI
73.49
Rel Volume
0.76
Avg Volume
619.84K
Volume
470.31K
Perf Week
8.35%
Perf Month
10.58%
Perf Quarter
71.35%
Perf Half Y
65.66%
-
-
-
-
Beta
0.951
-
-
Volatility
5.08%, 4.58%
Prev Close
1.53%
Price
146.69
Change
3.65%

MASI Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-30

Metric History 2019-12-282021-01-022022-01-012022-12-31 2023-12-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
16.4419.7222.4537.9838.79
Net income per share
3.444.144.162.681.54
Operating cash flow per share
3.893.644.80.551.78
Free cash flow per share
2.612.264.16-0.50.12
Cash per share
12.0611.0613.53.793.14
Book value per share
20.4724.2728.0824.9825.85
Tangible book value per share
19.6121.2224.953.19-4.69
Share holders equity per share
20.4724.2728.0824.9825.85
Interest debt per share
0.360.60.618.6818.46
Market cap
9.1B15.57B16.16B7.93B6.19B
Enterprise value
8.55B14.96B15.45B8.7B6.99B
P/E ratio
46.3664.7870.3955.2675.93
Price to sales ratio
9.713.6113.043.93.02
POCF ratio
41.0573.7961.04268.8265.77
PFCF ratio
60.99118.8270.32-295.9966.98
P/B Ratio
7.7911.0610.435.924.53
PTB ratio
7.7911.0610.435.924.53
EV to sales
9.1213.0812.474.273.41
Enterprise value over EBITDA
34.9452.6449.625.1426.63
EV to operating cash flow
38.5870.9158.3529574.31
EV to free cash flow
57.33114.1967.22-324.721.09K
Earnings yield
0.020.020.010.020.01
Free cash flow yield
0.020.010.0100
Debt to equity
0.020.020.020.730.68
Debt to assets
0.010.020.020.30.3
Net debt to EBITDA
-2.24-2.14-2.292.233.06
Current ratio
5.784.714.632.082.18
Interest coverage
674.44756.87776.968.173.27
Income quality
1.130.881.150.211.15
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.320.30.310.320
Research and developement to revenue
0.10.10.110.090.09
Intangibles to total assets
0.040.10.090.360.53
Capex to operating cash flow
-0.33-0.38-0.13-1.91-0.93
Capex to revenue
-0.08-0.07-0.03-0.03-0.04
Capex to depreciation
-3.09-2.73-0.98-0.41-0.89
Stock based compensation to revenue
0.040.040.040.020
Graham number
39.8147.5751.2738.7929.96
ROIC
0.150.160.140.070.07
Return on tangible assets
0.150.160.130.070.06
Graham Net
10.819.4911.95-20.22-17.47
Working capital
823.84M867.33M970.68M678.6M668.1M
Tangible asset value
1.12B1.23B1.38B170.9M-247.5M
Net current asset value
767.81M796.25M901.65M-563.1M-444.8M
Invested capital
0.020.020.020.730.68
Average receivables
121.03M136.89M171.06M323.33M433.45M
Average payables
47.47M59.3M69.84M176.21M264.15M
Average inventory
104.81M165.91M208.66M351.19M523M
Days sales outstanding
51.5445.1159.1479.9575.03
Days payables outstanding
64.558.3664.07103.4187.88
Days of inventory on hand
137.02196.72170.61187.17190.43
Receivables turnover
7.088.096.174.574.86
Payables turnover
5.666.255.73.534.15
Inventory turnover
2.661.862.141.951.92
ROE
0.170.170.150.110.06
Capex per share
-1.27-1.38-0.63-1.05-1.66

Quarterly Fundamentals Overview

Last date of statement is 2023-12-30 for Q4

Metric History 2022-12-312023-04-012023-07-012023-09-30 2023-12-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
11.7510.748.629.0710.4
Net income per share
0.780.40.30.20.64
Operating cash flow per share
-0.130.010.45-0.131.46
Free cash flow per share
-0.25-0.340.03-0.550.98
Cash per share
3.863.312.852.363.14
Book value per share
25.525.2924.7824.1625.85
Tangible book value per share
3.264.164.394.65-4.69
Share holders equity per share
25.525.2924.7824.1625.85
Interest debt per share
19.8118.3217.9918.5417.77
Market cap
7.77B9.71B8.69B4.63B6.19B
Enterprise value
8.59B10.43B9.43B5.42B6.99B
P/E ratio
47.48113.93138.35109.1945.64
Price to sales ratio
12.5917.1819.089.6711.27
POCF ratio
-1.18K24.27K368.15-661.3680.27
PFCF ratio
-597.49-545.335.79K-159.09119.47
P/B Ratio
5.87.36.643.634.53
PTB ratio
5.87.36.643.634.53
EV to sales
13.9318.4620.711.3112.74
Enterprise value over EBITDA
55.95162.72172.9685.0180.01
EV to operating cash flow
-1.3K26.08K399.42-773.690.7
EV to free cash flow
-661.02-585.976.28K-186.09134.99
Earnings yield
0.010000.01
Free cash flow yield
000-0.010.01
Debt to equity
0.770.720.720.760.68
Debt to assets
0.320.310.310.320.3
Net debt to EBITDA
5.3811.2913.5412.339.2
Current ratio
2.082.162.112.142.18
Interest coverage
6.433.222.481.974.7
Income quality
-0.160.021.5-0.662.27
Dividend Yield
00000
Payout ratio
00.570.0400
Sales general and administrative to revenue
0.280000
Research and developement to revenue
0.090.090.090.10.07
Intangibles to total assets
0.360.360.360.340.53
Capex to operating cash flow
0.97-45.5-0.943.16-0.33
Capex to revenue
-0.01-0.03-0.05-0.05-0.05
Capex to depreciation
-0.08-0.7-0.88-0.9-1.12
Stock based compensation to revenue
0.010.01-0.0200.02
Graham number
21.1415.1812.8810.4519.32
ROIC
0.020.010.010.010.04
Return on tangible assets
0.020.010.010.010.02
Graham Net
-19.8-19.98-19.3-19.62-17.47
Working capital
678.6M677.6M636.3M658.7M668.1M
Tangible asset value
170.9M218.6M231.7M245.5M-247.5M
Net current asset value
-563.1M-524.4M-494.7M-482.8M-444.8M
Invested capital
0.770.720.720.760.68
Average receivables
438.35M458.15M380M352.85M388.95M
Average payables
272.3M262.95M257.3M274.5M267.5M
Average inventory
498.2M502.25M523.05M563.6M564.8M
Days sales outstanding
73.6865.568.9567.0769.03
Days payables outstanding
82.0680.01102.07104.5379.09
Days of inventory on hand
148.52161.72208.6215.54171.38
Receivables turnover
1.221.371.311.341.3
Payables turnover
1.11.120.880.861.14
Inventory turnover
0.610.560.430.420.53
ROE
0.030.020.010.010.02
Capex per share
-0.12-0.35-0.42-0.42-0.48

MASI Frequently Asked Questions

What is Masimo Corporation stock symbol ?

Masimo Corporation is a US stock , located in Irvine of Ca and trading under the symbol MASI

Is Masimo Corporation buy or a sell ?

13 stock analysts have 13 predictions with a medium analyst target price of $161.46. The lowest prediction is $130 and the highest is $207

What is MASI stock prediction ?

With a median analyst target price of $158, 3 stock analysts have made 3 forecasts in last 90 days. $148 is the lowest and $166 is the greatest projection.

What is Masimo Corporation stock quote today ?

Masimo Corporation stock price is $146.69 today.

Is Masimo Corporation stock public?

Yes, Masimo Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap